BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sucandy I, Cheek S, Golas BJ, Tsung A, Geller DA, Marsh JW. Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors. HPB (Oxford). 2016;18:756-763. [PMID: 27593593 DOI: 10.1016/j.hpb.2016.06.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Weiss J, Rempp H, Clasen S, Notohamiprodjo M, Keßler DE, Pereira PL, Blumenstock G, Nikolaou K, Hoffmann R. Diagnostic accuracy of different magnetic resonance imaging sequences for detecting local tumor progression after radiofrequency ablation of hepatic malignancies. Eur J Radiol 2017;94:85-92. [PMID: 28655432 DOI: 10.1016/j.ejrad.2017.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
2 Yao XS, Yan D, Jiang XX, Li X, Zeng HY, Li H. Short-term outcomes of radiofrequency ablation for hepatocellular carcinoma using cone-beam computed tomography for planning and image guidance. World J Clin Cases 2021; 9(7): 1580-1591 [PMID: 33728301 DOI: 10.12998/wjcc.v9.i7.1580] [Reference Citation Analysis]
3 Jabbar F, Syblis C, Sucandy I. The use of thermal ablation in the treatment of colorectal liver metastasis-proper selection and application of technology. Hepatobiliary Surg Nutr 2021;10:279-80. [PMID: 33898578 DOI: 10.21037/hbsn-21-54] [Reference Citation Analysis]
4 Weiss J, Winkelmann MT, Gohla G, Kübler J, Clasen S, Nikolaou K, Hoffmann R. MR-guided microwave ablation in hepatic malignancies: clinical experiences from 50 procedures. Int J Hyperthermia 2020;37:349-55. [PMID: 32286087 DOI: 10.1080/02656736.2020.1750713] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
5 Sutphin PD, Ganguli S. Interventional Treatment of Hepatic Metastases from Colorectal Cancer. Semin Intervent Radiol 2020;37:492-8. [PMID: 33328705 DOI: 10.1055/s-0040-171919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Liu X, Plishker W, Kane TD, Geller DA, Lau LW, Tashiro J, Sharma K, Shekhar R. Preclinical evaluation of ultrasound-augmented needle navigation for laparoscopic liver ablation. Int J Comput Assist Radiol Surg 2020;15:803-10. [PMID: 32323211 DOI: 10.1007/s11548-020-02164-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Weiss J, Hoffmann R, Rempp H, Keβler DE, Pereira PL, Nikolaou K, Clasen S. Feasibility, efficacy, and safety of percutaneous MR-guided ablation of small (≤12 mm) hepatic malignancies. J Magn Reson Imaging 2019;49:374-81. [PMID: 30221797 DOI: 10.1002/jmri.26252] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Hong Y, Martin RCG. Personalizing Locoregional Therapy for Patients with Metastatic Colorectal Cancer. Curr Colorectal Cancer Rep 2017;13:126-35. [DOI: 10.1007/s11888-017-0356-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Murad HY, Bortz EP, Yu H, Luo D, Halliburton GM, Sholl AB, Khismatullin DB. Phenotypic alterations in liver cancer cells induced by mechanochemical disruption. Sci Rep 2019;9:19538. [PMID: 31862927 DOI: 10.1038/s41598-019-55920-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Daye D, Hu EY, Glazer DI, Tuncali K, Levesque V, Shyn PB. Periprocedural factors associated with overall patient survival following percutaneous image-guided liver tumor cryoablation. Int J Hyperthermia 2022;39:34-9. [PMID: 34937523 DOI: 10.1080/02656736.2021.2013552] [Reference Citation Analysis]
11 Ekmekcioglu O, Tabakci ON, Bozdag Kaplan N, Hasanefendioglu Bayrak A, Battal M. Factors affecting the response to treatment and survival in hepatocellular carcinoma patients treated with transarterial radioembolisation: a single-centre experience. Eur J Gastroenterol Hepatol 2021;33:926-31. [PMID: 33731592 DOI: 10.1097/MEG.0000000000002117] [Reference Citation Analysis]
12 Liu Z, Wang X, Xing L, Pan Y, Huang S. The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular Carcinoma. Cancer Biother Radiopharm 2019;34:621-5. [PMID: 31809215 DOI: 10.1089/cbr.2019.2845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Zarębska I, Gzil A, Durślewicz J, Jaworski D, Antosik P, Ahmadi N, Smolińska-Świtała M, Grzanka D, Szylberg Ł. The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers. Clin Res Hepatol Gastroenterol 2021;45:101664. [PMID: 33667731 DOI: 10.1016/j.clinre.2021.101664] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Reccia I, Sodergren MH, Jayant K, Kurz E, Carneiro A, Spalding D, Pai M, Jiao L, Habib N. The journey of radiofrequency-assisted liver resection. Surg Oncol 2018;27:A16-8. [PMID: 29449067 DOI: 10.1016/j.suronc.2018.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Welch BT, Schmitz JJ, Kurup AN, Atwell TD, Callstrom MR, Frey G, Paz-Fumagalli R, Allen A, Watt K, Heimbach J, Schmit GD. Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograft. Abdom Radiol (NY) 2018;43:1478-81. [PMID: 28936550 DOI: 10.1007/s00261-017-1323-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Hu M, Huang L. Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver. Adv Funct Mater 2018. [DOI: 10.1002/adfm.201805760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
17 Paprottka KJ, Schoeppe F, Ingrisch M, Rübenthaler J, Sommer NN, De Toni E, Ilhan H, Zacherl M, Todica A, Paprottka PM. Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients. Eur J Nucl Med Mol Imaging 2017;44:1185-93. [PMID: 28197686 DOI: 10.1007/s00259-017-3646-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
18 Mazmishvili K, Jayant K, Janikashvili N, Kikodze N, Mizandari M, Pantsulaia I, Paksashvili N, Sodergren MH, Reccia I, Pai M, Habib N, Chikovani T. Study to evaluate the immunomodulatory effects of radiofrequency ablation compared to surgical resection for liver cancer. J Cancer 2018;9:3187-95. [PMID: 30210642 DOI: 10.7150/jca.25084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
19 Liu M, Wang K, Wang Y, Bao Q, Wang H, Jin K, Liu W, Xing B. Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis. HPB (Oxford) 2021:S1365-182X(21)00096-4. [PMID: 33934959 DOI: 10.1016/j.hpb.2021.03.014] [Reference Citation Analysis]
20 Knešaurek K. Comparison of posttherapy 90Y positron emission tomography/computed tomography dosimetry methods in liver therapy with 90Y microspheres. World J Nucl Med 2020;19:359-65. [PMID: 33623505 DOI: 10.4103/wjnm.WJNM_23_20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Knešaurek K, Tuli A, Pasik SD, Heiba S, Kostakoglu L. Quantitative comparison of pre-therapy 99mTc-macroaggregated albumin SPECT/CT and post-therapy PET/MR studies of patients who have received intra-arterial radioembolization therapy with 90Y microspheres. Eur J Radiol 2018;109:57-61. [PMID: 30527312 DOI: 10.1016/j.ejrad.2018.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Hue YK, Guimaraes AR, Cohen O, Nevo E, Roth A, Ackerman JL. Magnetic Resonance Mediated Radiofrequency Ablation. IEEE Trans Med Imaging 2018;37:417-27. [PMID: 28922117 DOI: 10.1109/TMI.2017.2753739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
23 Xourafas D, Pawlik TM, Ejaz A, Dillhoff M, Abdel-misih S, Tsung A, Cloyd JM. Impact of concomitant ablation on the perioperative outcomes of patients with colorectal liver metastases undergoing hepatectomy: a propensity score matched nationwide analysis. HPB 2019;21:1079-86. [DOI: 10.1016/j.hpb.2018.12.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
24 Li G, Xue M, Chen W, Yi S. Efficacy and safety of radiofrequency ablation for lung cancers: A systematic review and meta-analysis. Eur J Radiol 2018;100:92-8. [PMID: 29496085 DOI: 10.1016/j.ejrad.2018.01.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
25 Knešaurek K. An estimate of 90Y dosimetry for bremsstrahlung SPECT/CT imaging in liver therapy with 90Y microspheres. Eur J Radiol 2021;139:109698. [PMID: 33848778 DOI: 10.1016/j.ejrad.2021.109698] [Reference Citation Analysis]
26 Tohra S, Duseja A, Taneja S, Kalra N, Gorsi U, Behera A, Kaman L, Dahiya D, Sahu S, Sharma B, Singh V, Dhiman RK, Chawla Y. Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis. J Clin Exp Hepatol 2021;11:682-90. [PMID: 34866847 DOI: 10.1016/j.jceh.2021.02.002] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Höppener DJ, Nierop PMH, van Amerongen MJ, Olthof PB, Galjart B, van Gulik TM, de Wilt JHW, Grünhagen DJ, Rahbari NN, Verhoef C. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival. Ann Surg Oncol 2019;26:2812-20. [PMID: 31147988 DOI: 10.1245/s10434-019-07481-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
28 Jeong Y, Park J, Lee J, Kim K, Park I. Ultrathin, Biocompatible, and Flexible Pressure Sensor with a Wide Pressure Range and Its Biomedical Application. ACS Sens 2020;5:481-9. [DOI: 10.1021/acssensors.9b02260] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]